Skip to main content

Table 2 The patient’s ward

From: Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

Ward

Male (cases)

Female (cases)

Age (years)

The first infectious disease department, ward 4 (A4)

15

23

55.50 ± 14.16

The first infectious disease department, ward 8 (A8)

29

23

58.01 ± 13.06

The first infectious disease department, ward 13 (A13)

24

22

64.56 ± 14.01

The second infectious disease department, ward 1 (B1)

36

30

69.35 ± 16.85